Table 1.
Case-Control Series for Rheumatoid Arthritis and Systemic Lupus Erythematosus.*
| Series | No. of Case Patients | No. of Controls |
|---|---|---|
| Rheumatoid arthritis | ||
| NARAC | 607 | 1309 |
| Replication series | 1013 | 1326 |
| EIRA | 1529 | 881 |
| Lupus† | ||
| UCSF | 575 | 416 |
| ABCoN | 349 | 416 |
| MADGC | 115 | 416 |
NARAC denotes the North American Rheumatoid Arthritis Consortium, EIRA the Epidemiological Investigation of Rheumatoid Arthritis, UCSF the University of California at San Francisco, ABCoN the Autoimmune Biomarkers Collabora-tive Network, and MADGC the Multiple Autoimmune Diseases Genetics Consortium.
The three sets of controls for the three lupus case-control series are 1248 in-dependent samples that were randomly assigned to the three series.